|
1
|
Salinas AJ, Shruti S, Malavasi G, Menabue
L and Vallet-Regi M: Substitutions of cerium, gallium and zinc in
ordered mesoporous bioactive glasses. Acta Biomater. 7:2741–3458.
2011. View Article : Google Scholar
|
|
2
|
Ma Z and Fu Q: Comparison of the
therapeutic effects of yeast-incorporated gallium with those of
inorganic gallium on ovariectomized osteopenic rats. Biol Trace
Elem Res. 134:280–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Collery P, Keppler B, Madoulet C and
Desoize B: Gallium in cancer treatment. Crit Rev Oncol Hematol.
42:283–296. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Warrell RP Jr, Bockman RS, Coonley CJ,
Isaacs M and Staszewski H: Gallium nitrate inhibits calcium
resorption from bone and is effective treatment for cancer-related
hypercalcemia. J Clin Invest. 73:1487–1490. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bockman RS: The effects of gallium nitrate
on bone resorption. Semin Oncol. 30:5–12. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Warrell RP Jr and Bockman RS: Gallium in
the treatment of hypercalcemia and bone metastasis. Important Adv
Oncol. 9:205–220. 1989.
|
|
7
|
Bockman RS and Bosco B: Treatment of
patients with advanced Pagets disease of bone with two cycles of
gallium nitrate. Semin Arthritis Rheum. 23:268–269. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hall TJ and Chambers TJ: Gallium inhibits
bone resorption by a direct effect on osteoclasts. Bone Miner.
8:211–216. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blumenthal NC, Cosma V and Levine S:
Effect of gallium on the in vitro formation, growth, and solubility
of hydroxyapatite. Calcif Tissue Int. 45:81–87. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verron E, Loubat A, Carle GF,
Vignes-Colombeix C, Strazic I, Guicheux J, Rochet N, Bouler JM and
Scimeca JC: Molecular effects of gallium on osteoclastic
differentiation of mouse and human monocytes. Biochem Pharmacol.
83:671–679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Makitie O: Causes, mechanisms and
management of paediatric osteoporosis. Nat Rev Rheumatol.
9:465–475. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rosen CJ and Bouxsein ML: Mechanisms of
disease: Is osteoporosis the obesity of bone? Nat Clin Pract
Rheumatol. 2:35–43. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rivadeneira F and Mäkitie O: Osteoporosis
and bone mass disorders: From gene pathways to treatments. Trends
Endocrinol Metab. 27:262–281. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu YH, Chen WY, Chan CH, Wu CH, Sun ZJ
and Chang MS: Anti-IL-20 monoclonal antibody inhibits the
differentiation of osteoclasts and protects against osteoporotic
bone loss. J Exp Med. 208:1849–1861. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kular J, Tickner JC, Pavlos NJ, Viola HM,
Abel T, Lim BS, Yang X, Chen H, Cook R, Hool C, et al: Choline
kinase β mutant mice exhibit reduced phosphocholine, elevated
osteoclast activity, and low bone mass. J Biol Chem. 290:1729–1742.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rodriguez JES, Mansky KC, Jensen ED,
Carlson AE, Schwarz T, Pham L, MacKenzie B, Prasad H, Rohrer MD,
Petryk A and Gopalakrishnan R: Enhanced osteoclastogenesis causes
osteopenia in twisted gastrulation-deficient mice through increased
BMP signaling. J Bone Miner Res. 24:1917–1926. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang D, Jing J, Lou F, Li R, Ping Y, Yu
F, Wu F, Yang X, Xu R, Li F, et al: Evidence for excessive
osteoclast activation in SIRT6 null mice. Sci Rep. 8:109922018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Theill LE, Boyle WJ and Penninger JM:
RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu
Rev Immunol. 20:795–823. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng C, Wentworth K and Shoback DM: New
frontiers in osteoporosis therapy. Annu Rev Med. 71:277–288. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou J, Ye J, Zhao X, Li A and Zhou J: JWA
is required for arsenic trioxide induced apoptosis in HeLa and
MCF-7 cells via reactive oxygen species and mitochondria linked
signal pathway. Toxicol Appl Pharmacol. 230:33–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Zu H, Zhao D, Yang K, Tian S, Yu
X, Lu F, Liu B, Yu X, Wang B, et al: Ion channel functional protein
kinase TRPM7 regulates Mg ions to promote the osteoinduction of
human osteoblast via PI3K pathway: In vitro simulation of the
bone-repairing effect of Mg-based alloy implant. Acta Biomater.
63:369–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Li JJ, Zhang J, Wang X, Kawazoe N
and Chen G: Gold nanoparticle size and shape influence on
osteogenesis of mesenchymal stem cells. Nanoscale. 8:7992–8007.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yao Y, Shi X and Chen F: The effect of
gold nanoparticles on the proliferation and differentiation of
murine osteoblast: A study of MC3T3-E1 cells in vitro. J Nanosci
Nanotechnol. 14:4851–4857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Kong N, Zhang Y, Yang W and Yan
F: Size-dependent effects of gold nanoparticles on osteogenic
differentiation of human periodontal ligament progenitor cells.
Theranostics. 7:1214–1224. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang C, Lin K, Chang J and Sun J:
Osteogenesis and angiogenesis induced by porous β-CaSiO3/PDLGA
composite scaffold via activation of AMPK/ERK1/2 and PI3K/AKT
pathways. Biomaterials. 34:64–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fang Y, Xue Z, Zhao L, Yang X, Yang Y,
Zhou X, Feng S and Chen K: Calycosin stimulates the osteogenic
differentiation of rat calvarial osteoblasts by activating the
IGF1R/PI3K/AKT signaling pathway. Cell Biol Int. 43:323–332. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ida-Yonemochi H, Nakagawa E, Takata H,
Furuyashiki T, Kakutani R, Tanaka M and Ohshima H: Extracellular
enzymatically synthesized glycogen promotes osteogenesis by
activating osteoblast differentiation via AKT/GSK-3β signaling
pathway. J Cell Physiol. 234:13602–13616. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chitambar CR: Gallium and its competing
roles with iron in biological systems. Biochim Biophys Acta.
1863:2044–2053. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dudley H and Maddox G: Deposition of radio
gallium (Ga72) in skeletal tissues. J Pharmacol Exp Ther.
96:224–227. 1949.PubMed/NCBI
|
|
31
|
Chitambar CR, Purpi DP, Woodliff J, Yang M
and Wereley JP: Development of gallium compounds for treatment of
lymphoma: Gallium maltolate, a novel hydroxypyrone gallium
compound, induces apoptosis and circumvents lymphoma cell
resistance to gallium nitrate. J Pharmacol Exp Ther. 322:1228–1236.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Casper E, Stanton G, Sordillo P, Parente
R, Michaelson R and Vinceguerra V: Phase II trial of gallium
nitrate in patients with advanced malignant melanoma. Cancer Treat
Rep. 69:1019–1020. 1985.PubMed/NCBI
|
|
33
|
Malfetano JH, Blessing JA and Adelson MD:
A phase II trial of gallium nitrate (NSC #15200) in previously
treated ovarian carcinoma. A gynecologic oncology group study. Am J
Clin Oncol. 14:349–351. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chitambar CR: Medical applications and
toxicities of gallium compounds. Int J Environ Res Public Health.
7:2337–2361. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matkovic V, Balboa AM, Clinchot D,
Whitacre CC, Zwilling BS, Brown D, Weisbrode SE, Apseloff G and
Gerber N: Gallium prevents adjuvant arthritis in rats and
interferes with macrophage. Curr Ther Res. 50:255–267. 1991.
|
|
36
|
Nomoto H, Maehashi H, Shirai M, Nakamura
M, Masaki T, Mezaki Y, Park J, Aizawa M, Ohkawa K, Yoshida K and
Matsuura T: Bio-artificial bone formation model with a radial-flow
bioreactor for implant therapy-comparison between two cell culture
carriers: Porous hydroxyapatite and β-tricalcium phosphate beads.
Hum Cell. 32:1–11. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fleig A and Penner R: The TRPM ion channel
subfamily: Molecular, biophysical and functional features. Trends
Pharmacol Sci. 25:633–639. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Harteneck C: Function and pharmacology of
TRPM cation channels. Naunyn Schmiedebergs Arch Pharmacol.
371:307–314. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nadler MJ, Hermosura MC, Inabe K, Perraud
AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg
AM and Fleig A: LTRPC7 is a Mg.ATP-regulated divalent cation
channel required for cell viability. Nature. 411:590–595. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Runnels LW, Yue L and Clapham DE:
TRP-PLIK, a bifunctional protein with kinase and ion channel
activities. Science. 291:1043–1047. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Schmitz C, Dorovkov MV, Zhao X, Davenport
BJ, Ryazanov AG and Perraud AL: The channel kinases TRPM6 and TRPM7
are functionally nonredundant. J Biol Chem. 280:37763–37771. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guntur AR and Rosen CJ: The skeleton: A
multi-functional complex organ: New insights into osteoblasts and
their role in bone formation: The central role of PI3kinase. J
Endocrinol. 211:1232011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Choi YH, Kim YJ, Jeong HM, Jin YH, Yeo CY
and Lee KY: AKT enhances Runx2 protein stability by regulating
Smurf2 function during osteoblast differentiation. FEBS J.
281:3656–3666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu X, Huang Y, Collin-Osdoby P and Osdoby
P: CCR1 chemokines promote the chemotactic recruitment, RANKL
development, and motility of osteoclasts and are induced by
inflammatory cytokines in osteoblasts. J Bone Miner Res.
19:2065–2077. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Neve A, Corrado A and Cantatore FP:
Osteoblast physiology in normal and pathological conditions. Cell
Tissue Res. 343:289–302. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dirckx N, Van Hul M and Maes C: Osteoblast
recruitment to sites of bone formation in skeletal development,
homeostasis, and regeneration. Birth Defects Res C Embryo Today.
99:170–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
